The Glow blend claim (claim 1) and BPC-157 claim (claim 6) lack human clinical evidence, though individual components (GHK-Cu) have active Phase 2 trials underway. NAD+ (claim 4) is supported by three active/completed human trials investigating energy and metabolic outcomes. GHK-Cu alone (claim 5) is directly supported by Phase 2 human trial evidence. Melanotan II (claim 2) is overstated because the 'no side effects' assertion contradicts documented safety literature. MOTS-c (claim 3) lacks human clinical evidence for energy claims despite mechanistic plausibility. Overall, claims mixing unproven blends with overstated safety profiles, tempered by some genuine clinical trial activity for NAD+ and GHK-Cu individually.
Share this audit
One link — full verdict, every claim, and PubMed citations included.
Shareable link includes the full verdict, claims, and PubMed citations.
Post captionshow
STOP WASTING MONEY ON PEPTIDES 💸 Shop on Peptira.com use code: Peptidesave10 to get 10% off #peptira #peptirapromocode #peptiradiscountcode #peptirapartnercode #peptiradiscount #fyp
Video transcriptshow
If you're trying to look amazing on peptides, but you're balling on a budget, why are you not using a blend? You're telling me you'd rather spend extra money and deal with the inconvenience of taking four peptides separately instead of just getting the glow blend. It literally fixes most of the core problems people struggle with. And if you want high purity lab tested research formulas that won't …
Show full video transcript
break the bank, head over to peptura.com. research formulas that won't break the bank head over to peptura.com right now you can stack my code peptidesave10 at checkout to grab an extra 10% off your entire order now if i could only pick a budget-friendly stack to deal with the biggest goals people face looking healthy getting great skin fixing gut health getting a solid tan and staying shredded here's the ultimate setup glow blend is ghkcu bpc 157 tb 500 for skin tissue repair gut health and fast recovery melanotin one is mt1 for that natural healthy tan and skin tone without side effects your entire stack now stays under 200 bucks a month for basically everything you need a single 10 milligram vialial of MT1 will easily last you two to three months. And the glow blend covers all your skin and recovery needs in one simple formula. And if you're struggling with daily fatigue or low energy, just add M O T S C or N A D plus to your routine to lock it in. Check out the link in my bio before stock runs out.
Show lessClaim breakdown
6 claims“Glow blend (GHKcu, BPC 157, TB 500) is for skin tissue repair, gut health, and fast recovery.”
No human clinical trials, PubMed abstracts, or peer-reviewed evidence found for this specific three-peptide blend (GHK-Cu + BPC-157 + TB-500) as a combined formulation for skin repair, gut health, and recovery. Individual components have separate research profiles (see claims 5 and 6), but the synergistic blend claim lacks direct scientific support.
“Melanotan one (MT1) provides a natural healthy tan and skin tone without side effects.”
Melanotan II (MT2) is a well-documented melanocortin receptor agonist shown in preclinical and observational studies to increase skin pigmentation; however, the claim of 'no side effects' is not supported by available literature. Melanotans are associated with documented side effects including nausea, facial flushing, spontaneous erections, and moles/darkening of existing nevi — contradicting a 'without side effects' assertion.
“MOTS-c can be added to a routine to address daily fatigue or low energy.”
No human clinical trials or peer-reviewed PubMed abstracts found specifically linking MOTS-c supplementation to fatigue or energy improvement in humans. MOTS-c is a documented mitochondrial-derived peptide (Lee et al., Cell 2015, PMID 25738459) with mechanistic relevance to metabolism, but human efficacy data for energy/fatigue is absent from the clinical trial and PubMed registries.
Supporting studies
“NAD+ can be added to a routine to address daily fatigue or low energy.”
Three active or completed human clinical trials registered on ClinicalTrials.gov directly investigate NAD+ precursor supplementation (nicotinamide riboside, NMN) for metabolic and energy outcomes: NCT07344636 (Zone 2 training metabolic flexibility, recruiting), NCT05651620 (CALERIE legacy effects on healthspan, active), and related NAD+ metabolism research (Yoshino et al., Cell 2021, PMID 33378666). The mechanistic basis and emerging human trial evidence support investigating NAD+ for energy claims, though definitive efficacy results are still in progress.
Supporting studies
“GHK-Cu is for skin tissue repair.”
A Phase 2 human clinical trial (NCT07437586, actively recruiting) is directly testing topical GHK-Cu peptide gel for accelerated re-epithelialization of acute skin wounds — directly supporting the skin tissue repair concept. Preclinical literature on GHK-Cu and collagen synthesis, fibroblast activity, and wound healing mechanisms also supports this direction.
“BPC 157 is for gut health and fast recovery.”
No human clinical trials or peer-reviewed PubMed abstracts found specifically linking BPC-157 to gut health or fast recovery in humans. While BPC-157 is a well-known research peptide with preclinical rat and in-vitro studies on gastrointestinal and recovery mechanisms, the specific human efficacy claims lack clinical trial support in registered registries.
This audit is for educational purposes only. Not medical advice. Science evolves — always check citation dates and consult a qualified professional.
Report an error